Selection of invalid instruments can improve estimation in mendelian randomization por Patel, A, Ditraglia, F, Zuber, V, Burgess, S

Mendelian randomization with fine‐mapped genetic data: choosing from large numbers of correlated instrumental variables por Burgess, S, Zuber, V, Valdez-Marquez, E, Sun, B, Hopewell, J

Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer. por Zuber, V, Bettella, F, Witoelar, A, Andreassen, O, Mills, I, Urbanucci, A

The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study por Ioannidou, A, Watts, EL, Perez-Cornago, A, Platz, EA, Mills, IG, Key, TJ, Travis, RC, Tsilidis, KK, Zuber, V

Identification of shared genetic variants between schizophrenia and lung cancer. por Zuber, V, Jönsson, E, Frei, O, Witoelar, A, Thompson, W, Schork, A, Bettella, F, Wang, Y, Djurovic, S, Smeland, O, Dieset, I, Fanous, A, Desikan, R, Küry, S, Bézieau, S, Dale, A, Mills, I, Andreassen, O

Identification and validation of leucine-rich α-2-glycoprotein 1 as a noninvasive biomarker for improved precision in prostate cancer risk stratification por Guldvik, IJ, Zuber, V, Braadland, PR, Grytli, HH, Ramberg, H, Lilleby, W, Thiede, B, Zucknick, M, Saatcioglu, F, Gislefoss, R, Kvåle, R, George, A, Grönberg, H, Wiklund, F, Neal, DE, Gnanapragasam, VJ, Taskén, KA, Mills, IG

Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes por Haglund, A, Zuber, V, Abouzeid, M, Yang, Y, Ko, JH, Wiemann, L, Otero-Jimenez, M, Muhammed, L, Feleke, R, Nott, A, Mills, JD, Laaniste, L, Gveric, DO, Clode, D, Babtie, AC, Pagni, S, Bellampalli, R, Somani, A, McDade, K, Anink, JJ, Mesarosova, L, Fancy, N, Willumsen, N, Smith, A

Pleiotropic analysis of lung cancer and blood triglycerides. por Zuber, V, Marconett, C, Shi, J, Hua, X, Wheeler, W, Yang, C, Song, L, Dale, A, Laplana, M, Risch, A, Witoelar, A, Thompson, W, Schork, A, Bettella, F, Wang, Y, Djurovic, S, Zhou, B, Borok, Z, van der Heijden, H, de Graaf, J, Swinkels, D, Aben, K, McKay, J, Hung, R, Bikeböller, H, Stevens, V, Albanes, D, Caporaso, N, Han, Y, Wei, Y, Panadero, M, Mayordomo, J, Christiani, D, Kiemeney, L, Andreassen, O, Houlston, R, Amos, C, Chatterjee, N, Laird-Offringa, I, Mills, I, Landi, M

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. por Seibert, TM, Fan, CC, Wang, Y, Zuber, V, Karunamuni, R, Parsons, JK, Eeles, RA, Easton, DF, Kote-Jarai, Z, Olama, AA, Garcia, SB, Muir, K, Grönberg, H, Wiklund, F, Aly, M, Schleutker, J, Sipeky, C, Tammela, TL, Nordestgaard, BG, Nielsen, SF, Weischer, M, Bisbjerg, R, Røder, MA, Iversen, P, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, K-T, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Brenner, H, Cuk, K, Saum, K-U, Park, JY, Sellers, TA, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Karow, DS, Mills, IG, Andreassen, OA, Dale, AM